Technical Papers

269 Results

Biomarkers of Toxicity Panel in Clinical Trials

Biomarkers of Toxicity Panel in Clinical Trials

ACM Global Central Laboratory | 18-Sep-2012 | Technical / White Paper

Most drug candidates are discontinued because of induced organ toxicity and half of them owe this to liver toxicity. This issue explains why drug developers...

505(b)(2): Fast and Cost-Effective Drug Approval

505(b)(2): Fast and Cost-Effective Drug Approval

Camargo Pharmaceutical Services | 10-Sep-2012 | Data Sheet

Looking to identify a new product for development or improve an existing compound? For lower risk, reduced cost and faster speed to market, Camargo Pharmaceutical...

New Early Phase Concepts: Practical Implementation

New Early Phase Concepts: Practical Implementation

SGS Life Science Services | 03-Sep-2012 | Technical / White Paper

There is an urgent need to use innovative techniques in early development. This paper will discuss several case studies in which new clinical trial methods...

Molecular Imaging Inc

Utility of FDG PET in Drug Development

Molecular Imaging Inc. | 20-Aug-2012 | Technical / White Paper

Imaging metabolism with FDG PET offers reliable and clinically translatable biomarkers for evaluation of candidate compounds. It can also:Provide a reliable...

Connecting Perfectly At Every Stage

Connecting Perfectly At Every Stage

Parexel | 30-Jul-2012 | Data Sheet

We believe in one bond that's more important than all others. Download our brochure to see how PAREXEL can help to optimize your product value.

Enhanced Rheumatoid Arthritis CIA and CAIA Studies

Enhanced Rheumatoid Arthritis CIA and CAIA Studies

Molecular Imaging Inc. | 23-Jul-2012 | Data Sheet

Detect disease modification with biomarker imaging using PET, FMT & CT to assess treatment response. Enhance decision making withcomplementary end...

Vaccine-Based Clinical Trials

Vaccine-Based Clinical Trials

SGS Life Science Services | 09-Jul-2012 | Technical / White Paper

Download this paper to read two case studies which illustrate strategies for planning and implementing a vaccine-based infectious disease clinical trial...

The new product development reality

The new product development reality

Parexel | 25-Jun-2012 | Technical / White Paper

While winning FDA or other regulatory approval is a formidable hurdle, it is no longer the end game when it comes to defining if the development of a product...

505(b)(2): Fast and Cost-Effective Drug Approval

505(b)(2): Fast and Cost-Effective Drug Approval

Camargo Pharmaceutical Services | 20-Jun-2012 | Data Sheet

Looking to embark on a 505(b)(2) product approval?More products than ever are approved via the 505(b)(2) pathway — a fast and cost-effective route for...

Pharmaceutical Outsourcing - key success factors

Pharmaceutical Outsourcing - key success factors

Alkermes Contract Pharma Services | 13-Jun-2012 | Technical / White Paper

It is now considered a sound strategic move by pharmaceutical companies, from big pharma to smaller players, to increasingly rely on outsourcing service...

505(b)(2): Fast and Cost-Effective Drug Approval

505(b)(2): Fast and Cost-Effective Drug Approval

Camargo Pharmaceutical Services | 28-May-2012 | Data Sheet

As a fast and cost-effective route for drug approval, more products than ever are approved via the 505(b)(2) pathway. Camargo Pharmaceutical Services is...

A Clinical Perspective on IV Medication Delivery

A Clinical Perspective on IV Medication Delivery

Baxter BioPharma Solutions | 09-Apr-2012 | Technical / White Paper

Management of medication delivery through intravenous (IV) administration is a complex and challenging task for pharmacists.  The information provided...

Sample Prep Proposed USP<233> Elemental Impurities

Sample Prep Proposed USP<233> Elemental Impurities

SGS Life Science Services | 27-Feb-2012 | Technical / White Paper

Proper sample preparation is crucial when analyzing for trace metals using inductively coupled plasma (ICP). This paper illustrates how solubility of the...

How to Approach Identification of Anomalous Peaks

How to Approach Identification of Anomalous Peaks

SGS Life Science Services | 22-Feb-2012 | Technical / White Paper

The sudden appearance of an unknown peak during an HPLC analysis of a pharmaceutical product can be a critical finding causing delays and requiring considerable...